Network analysis of membranous glomerulonephritis based on metabolomics data

Area of Science:

• Nephrology
• Metabolomics
• Systems Biology

Background:

• Membranous glomerulonephritis (MGN) is a leading cause of nephrotic syndrome in adults.
• Current diagnostic methods rely on invasive renal biopsy and limited biomarkers.
• There is a critical need for more sensitive and accessible diagnostic tools for MGN.

Purpose of the Study:

• To identify novel diagnostic metabolite biomarkers for membranous glomerulonephritis (MGN).
• To utilize topological features within a component-reaction-enzyme-gene (CREG) network for biomarker discovery.
• To explore protein-protein interaction (PPI) networks to understand disease mechanisms.

Main Methods:

• Differential metabolite analysis using proton nuclear magnetic resonance (1H NMR) and gas chromatography-mass spectrometry (GC-MS).
• Construction and analysis of a CREG network to identify hub metabolites.
• Protein-protein interaction (PPI) network analysis including molecular complex detection and Gene Ontology analysis.

Main Results:

• Twenty-six metabolites were identified as hub nodes in the CREG network.
• Thirteen key metabolites, including dopamine, carnosine, and fumarate, showed significant centrality and fold-change.
• Gene Ontology analysis revealed associations with pyrimidine and purine metabolism, and aromatic amino acid metabolism.

Conclusions:

• The identified metabolites represent potential novel biomarkers for diagnosing membranous glomerulonephritis.
• Network-based analysis provides a powerful approach for discovering disease-associated metabolites.
• Further validation studies are necessary to confirm the clinical utility of these biomarkers for MGN.